Roger McIntyre M.D., FRCPC

Roger McIntyre, M.D., FRCPC, is the CEO of AltMed Capital, President and CEO of CRTCE, a Professor of Psychiatry and Pharmacology at the University of Toronto and the Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada.

In addition, Dr. McIntyre serves as Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada; the Director as well as Co-Chair of the Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA) from Chicago, Illinois, USA; Professor and Nanshan Scholar at Guangzhou Medical University; and Adjunct Professor College of Medicine at Korea University.

Dr. McIntyre is a Clinical Professor at State University of New York (SUNY) Upstate Medical University, Syracuse, New York, USA and Clinical Professor Department of Psychiatry and Neurosciences University of California School of Medicine, Riverside, California, USA.

He was named by Clarivate Analytics in 2014, 2015, 2016, 2017, 2018 and 2019 as one of “The World’s Most Influential Scientific Minds”. Dr. McIntyre is the most recognized psychiatrist in the world in mood disorders. He has extensive collaboration with private sector partners including but not limited to the pharmaceutical industry, the insurance industry and health care industry in Canada, the United States and globally.

Dr. McIntyre has published over 600 articles on the topic of mood disorders and has published an extensive number of books and chapters, and has delivered thousands of lectures nationally and internationally on the topic of mood disorders.